INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
University of Nebraska Medical Center
Omaha, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Nebraska Medical Center (12)
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials
Leukemia, Vol. 35, Núm. 1, pp. 18-30
-
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
The Lancet Oncology, Vol. 22, Núm. 3, pp. e105-e118
2017
-
Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice
Blood, Vol. 129, Núm. 19, pp. 2645-2656
2016
2015
-
Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation
Proceedings of the National Academy of Sciences of the United States of America, Vol. 112, Núm. 10, pp. E1116-E1125
2014
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
British Journal of Haematology, Vol. 167, Núm. 4, pp. 466-477
-
Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma
Nature Communications, Vol. 5
2012
-
Guidelines for the use and interpretation of assays for monitoring autophagy
Autophagy, Vol. 8, Núm. 4, pp. 445-544
2007
-
A phase II multicenter study of troxacitabine in relapsed or refractory lymphoproliferative neoplasms or multiple myeloma
Leukemia and Lymphoma, Vol. 48, Núm. 1, pp. 39-45
1990
-
Molecular structure of the rearranged t-cell gamma chain gene in a human leukemia which expresses its product
Leukemia and Lymphoma, Vol. 3, Núm. 2, pp. 145-150